↓ Skip to main content

Dove Medical Press

Article Metrics

Update on the clinical utility of once-daily tacrolimus in the management of transplantation

Overview of attention for article published in Drug Design, Development and Therapy, May 2015
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
1 Dimensions
Title
Update on the clinical utility of once-daily tacrolimus in the management of transplantation
Published in
Drug Design, Development and Therapy, May 2015
DOI 10.2147/dddt.s84301
Pubmed ID
Authors

Jane Revollo

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 May 2015.
All research outputs
#4,215,997
of 5,067,960 outputs
Outputs from Drug Design, Development and Therapy
#516
of 751 outputs
Outputs of similar age
#132,321
of 158,728 outputs
Outputs of similar age from Drug Design, Development and Therapy
#33
of 54 outputs
Altmetric has tracked 5,067,960 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 751 research outputs from this source. They receive a mean Attention Score of 2.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 158,728 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.